Are you a new member? Sign up now
Login area
| Sign up
close
EVEROLIMUS BIOGARAN - 5mg - 30
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01EG02 | G | Everolimus - 5mg | 11381/388 | 113121/1 | EVEROLIMUS BIOGARAN | 5mg | 30 | Tablet | Oral | Commercial and Trading Ressources SAL (CTR) | Ethypharm | France | L.L | 2.44 | E2 | Laboratoires Biogaran | France | 05/02/20 |
Drugs With Same Ingredients
| ATC | B/G | Ingredients | code | Registration Nb | Name | Dosage | Presentation | Form | Route | Agent | Laboratory | Country | Price | Pharmacist Margin | Stratum | Responsible Party Name | Responsible Party Country | Exch_date | %SUBSIDY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| L01EG02 | B | Everolimus - 5mg | 5897 | 218674/10 | AFINITOR | 5mg | 30 | Tablet | Oral | Khalil Fattal & Fils S.A.L. | Novartis Pharma Stein AG | Switzerland | 135,386,182 L.L | 2.44 | E2 | Novartis Pharma AG | Switzerland | 12/12/20 | 0 |
| L01EG02 | G | Everolimus - 5mg | 11381 | 113121/1 | EVEROLIMUS BIOGARAN | 5mg | 30 | Tablet | Oral | Commercial and Trading Ressources SAL (CTR) | Ethypharm | France | 89,386,347 L.L | 2.44 | E2 | Laboratoires Biogaran | France | 12/12/20 | 0 |
| L01EG02 | G | Everolimus - 5mg | 10482 | 2320/1 | EVEROLIMUS ARROW | 5mg | 30 | Tablet | Oral | Darapharma S.A.L. | Ethypharm | France | 66,619,921 L.L | 10.71 | E1 | Arrow Génériques | France | 12/12/20 | 0 |
| L01EG02 | G | Everolimus - 5mg | 10482/388 | 2320/1 | EVEROLIMUS ARROW | 5mg | 30 | Tablet | Oral | Darapharma S.A.L. | Ethypharm | France | L.L | 10.71 | E1 | Arrow Génériques | France | 05/02/20 |
Sitemap
© Copyrights reserved to Ministry of Public Health 2024